baclofen has been researched along with Disease Exacerbation in 19 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Intrathecal baclofen (ITB) is an effective treatment of spasticity in patients with cerebral palsy." | 9.13 | The impact of intrathecal baclofen on the natural history of scoliosis in cerebral palsy. ( Cabrera, MN; Frino, J; Lai, LP; Shilt, JS; Smith, BP, 2008) |
| "In patients with cerebral palsy (CP), we determine the impact of intrathecal baclofen pumps (ITBPs) on scoliosis curve progression before posterior spine fusion (PSF) and its effects on surgical outcome." | 7.96 | Does an intrathecal baclofen pump impact scoliosis progression and complicate posterior spine fusion in patients with cerebral palsy? ( Halanski, MA; Hetzel, SJ; Lins, LAB; Nechyporenko, AV; Noonan, KJ, 2020) |
| "Compare a group of individuals with cerebral palsy (CP) who had intrathecal baclofen (ITB) pumps to a group of individuals with CP who did not have ITB pumps in order to determine if there was a difference in the prevalence of new-onset neuromuscular scoliosis, an increased rate of progression of preexisting neuromuscular scoliosis, or an increased rate of posterior spine fusion surgery in skeletally immature individuals with CP who had ITB pumps." | 7.85 | Does Intrathecal Baclofen Therapy Increase Prevalence and/or Progression of Neuromuscular Scoliosis? ( Krach, LE; Novotny, SA; Walker, KR, 2017) |
| "To compare scoliosis progression in quadriplegic spastic cerebral palsy with and without intrathecal baclofen (ITB) pumps." | 7.85 | Intrathecal baclofen pumps do not accelerate progression of scoliosis in quadriplegic spastic cerebral palsy. ( Ammar, A; Aujla, RK; Grevitt, MP; Nasto, LA; Rushton, PRP; Vloeberghs, MH, 2017) |
| "Intrathecal baclofen is an effective treatment for spasticity in patients with cerebral palsy." | 7.76 | Do baclofen pumps influence the development of scoliosis in children? ( Burn, SC; Drake, JM; Zeller, R, 2010) |
| "To identify the effect of intrathecal baclofen on the incidence of scoliosis, rate of curve progression, and pelvic obliquity compared with a matched cohort." | 7.74 | The risk of progression of scoliosis in cerebral palsy patients after intrathecal baclofen therapy. ( Dabney, KW; Glutting, JW; Miller, F; Presedo, A; Senaran, H; Shah, SA, 2007) |
| "Medical and radiographic review of 19 consecutive patients with spastic quadriplegia before and after intrathecal baclofen pump insertion with special attention paid to progression of scoliosis." | 7.74 | Progression of scoliosis in patients with spastic quadriplegia after the insertion of an intrathecal baclofen pump. ( Ginsburg, GM; Lauder, AJ, 2007) |
| "Spasticity is the major etiology for hip dislocation in nonambulatory cerebral palsy patients." | 5.38 | A comparison of hip dislocation rates and hip containment procedures after selective dorsal rhizotomy versus intrathecal baclofen pump insertion in nonambulatory cerebral palsy patients. ( Ayyangar, RN; Caird, MS; Craig, CL; Farley, FA; Hensinger, RN; Hurvitz, EA; Nowicki, P; Silva, S; Vanderhave, KL, 2012) |
| "We report a case of dystonia with a partial deletion of the short arm (p) of chromosome 18 and androgen insensitivity." | 5.30 | Progressive dystonia in a child with chromosome 18p deletion, treated with intrathecal baclofen. ( Awaad, Y; Munoz, S; Nigro, M, 1999) |
| "Intrathecal baclofen (ITB) is an effective treatment of spasticity in patients with cerebral palsy." | 5.13 | The impact of intrathecal baclofen on the natural history of scoliosis in cerebral palsy. ( Cabrera, MN; Frino, J; Lai, LP; Shilt, JS; Smith, BP, 2008) |
| "In patients with cerebral palsy (CP), we determine the impact of intrathecal baclofen pumps (ITBPs) on scoliosis curve progression before posterior spine fusion (PSF) and its effects on surgical outcome." | 3.96 | Does an intrathecal baclofen pump impact scoliosis progression and complicate posterior spine fusion in patients with cerebral palsy? ( Halanski, MA; Hetzel, SJ; Lins, LAB; Nechyporenko, AV; Noonan, KJ, 2020) |
| "Compare a group of individuals with cerebral palsy (CP) who had intrathecal baclofen (ITB) pumps to a group of individuals with CP who did not have ITB pumps in order to determine if there was a difference in the prevalence of new-onset neuromuscular scoliosis, an increased rate of progression of preexisting neuromuscular scoliosis, or an increased rate of posterior spine fusion surgery in skeletally immature individuals with CP who had ITB pumps." | 3.85 | Does Intrathecal Baclofen Therapy Increase Prevalence and/or Progression of Neuromuscular Scoliosis? ( Krach, LE; Novotny, SA; Walker, KR, 2017) |
| "To compare scoliosis progression in quadriplegic spastic cerebral palsy with and without intrathecal baclofen (ITB) pumps." | 3.85 | Intrathecal baclofen pumps do not accelerate progression of scoliosis in quadriplegic spastic cerebral palsy. ( Ammar, A; Aujla, RK; Grevitt, MP; Nasto, LA; Rushton, PRP; Vloeberghs, MH, 2017) |
| "Intrathecal baclofen is an effective treatment for spasticity in patients with cerebral palsy." | 3.76 | Do baclofen pumps influence the development of scoliosis in children? ( Burn, SC; Drake, JM; Zeller, R, 2010) |
| "To identify the effect of intrathecal baclofen on the incidence of scoliosis, rate of curve progression, and pelvic obliquity compared with a matched cohort." | 3.74 | The risk of progression of scoliosis in cerebral palsy patients after intrathecal baclofen therapy. ( Dabney, KW; Glutting, JW; Miller, F; Presedo, A; Senaran, H; Shah, SA, 2007) |
| "Medical and radiographic review of 19 consecutive patients with spastic quadriplegia before and after intrathecal baclofen pump insertion with special attention paid to progression of scoliosis." | 3.74 | Progression of scoliosis in patients with spastic quadriplegia after the insertion of an intrathecal baclofen pump. ( Ginsburg, GM; Lauder, AJ, 2007) |
| " They also required higher doses and more rapid dosage increases." | 2.68 | Intrathecal baclofen therapy for stiff-man syndrome and progressive encephalomyelopathy with rigidity and myoclonus. ( Dressnandt, J; Marquardt, G; Mauch, E; Meinck, HM; Müller-Schwefe, G; Rieke, K; Schumm, F; Stayer, C; Tronnier, V, 1997) |
| "All children are known to have severe dyskinetic cerebral palsy and presented with an acute or sub-acute deterioration in their symptoms." | 1.43 | Status dystonicus in children: Early recognition and treatment prevent serious complications. ( Abu-Arafeh, I; Combe, L, 2016) |
| "Spasticity is the major etiology for hip dislocation in nonambulatory cerebral palsy patients." | 1.38 | A comparison of hip dislocation rates and hip containment procedures after selective dorsal rhizotomy versus intrathecal baclofen pump insertion in nonambulatory cerebral palsy patients. ( Ayyangar, RN; Caird, MS; Craig, CL; Farley, FA; Hensinger, RN; Hurvitz, EA; Nowicki, P; Silva, S; Vanderhave, KL, 2012) |
| "We report a 21-yr-old male patient with spondyloepiphyseal dysplasia tarda with progressive arthropathy who developed spastic paraplegia because of spinal stenosis caused by thoracic disk herniations." | 1.37 | Spondyloepiphyseal dysplasia tarda with progressive arthropathy complicated with paraplegia. ( Gelal, F; Memi, A; Olmez, N; Oz, B; Yoleri, O, 2011) |
| "We report a case of dystonia with a partial deletion of the short arm (p) of chromosome 18 and androgen insensitivity." | 1.30 | Progressive dystonia in a child with chromosome 18p deletion, treated with intrathecal baclofen. ( Awaad, Y; Munoz, S; Nigro, M, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 9 (47.37) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Lins, LAB | 1 |
| Nechyporenko, AV | 1 |
| Halanski, MA | 1 |
| Hetzel, SJ | 1 |
| Noonan, KJ | 1 |
| Walker, KR | 1 |
| Novotny, SA | 1 |
| Krach, LE | 1 |
| Arroyo González, R | 1 |
| Parigi, L | 1 |
| Torta, M | 1 |
| Barbero, R | 1 |
| Boncristiano, DM | 1 |
| Clerici, D | 1 |
| Meduri, E | 1 |
| Rigano, A | 1 |
| Vendramin, S | 1 |
| Rushton, PRP | 1 |
| Nasto, LA | 1 |
| Aujla, RK | 1 |
| Ammar, A | 1 |
| Grevitt, MP | 1 |
| Vloeberghs, MH | 1 |
| Combe, L | 1 |
| Abu-Arafeh, I | 1 |
| Morishita, A | 1 |
| Aihara, H | 1 |
| Nakai, T | 1 |
| Adachi, M | 1 |
| Karneev, AN | 1 |
| Solov'eva, EIu | 1 |
| Fedin, AI | 1 |
| Shilt, JS | 1 |
| Lai, LP | 1 |
| Cabrera, MN | 1 |
| Frino, J | 1 |
| Smith, BP | 1 |
| Bonouvrié, LA | 1 |
| van Schie, PE | 1 |
| Becher, JG | 1 |
| van Ouwerkerk, WJ | 1 |
| Vermeulen, RJ | 1 |
| Burn, SC | 1 |
| Zeller, R | 1 |
| Drake, JM | 1 |
| Yoleri, O | 1 |
| Oz, B | 1 |
| Olmez, N | 1 |
| Memi, A | 1 |
| Gelal, F | 1 |
| Silva, S | 1 |
| Nowicki, P | 1 |
| Caird, MS | 1 |
| Hurvitz, EA | 1 |
| Ayyangar, RN | 1 |
| Farley, FA | 1 |
| Vanderhave, KL | 1 |
| Hensinger, RN | 1 |
| Craig, CL | 1 |
| Hart, AR | 1 |
| Tripathi, C | 1 |
| Rowland, DJ | 1 |
| Broadley, P | 1 |
| Mordekar, SR | 1 |
| Senaran, H | 1 |
| Shah, SA | 1 |
| Presedo, A | 1 |
| Dabney, KW | 1 |
| Glutting, JW | 1 |
| Miller, F | 1 |
| Ginsburg, GM | 1 |
| Lauder, AJ | 1 |
| Stayer, C | 1 |
| Tronnier, V | 1 |
| Dressnandt, J | 1 |
| Mauch, E | 1 |
| Marquardt, G | 2 |
| Rieke, K | 1 |
| Müller-Schwefe, G | 1 |
| Schumm, F | 1 |
| Meinck, HM | 1 |
| Awaad, Y | 1 |
| Munoz, S | 1 |
| Nigro, M | 1 |
| Lorenz, R | 1 |
1 review available for baclofen and Disease Exacerbation
| Article | Year |
|---|---|
A review of the effects of baclofen and of THC:CBD oromucosal spray on spasticity-related walking impairment in multiple sclerosis.
Topics: Baclofen; Cannabidiol; Disease Progression; Dronabinol; Drug Combinations; Gait Disorders, Neurologi | 2018 |
3 trials available for baclofen and Disease Exacerbation
| Article | Year |
|---|---|
The use of baklosan in the complex treatment of back pain.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Back Pain; Baclofen; Disease Progr | 2007 |
The impact of intrathecal baclofen on the natural history of scoliosis in cerebral palsy.
Topics: Adolescent; Baclofen; Case-Control Studies; Cerebral Palsy; Child; Child, Preschool; Disease Progres | 2008 |
Intrathecal baclofen therapy for stiff-man syndrome and progressive encephalomyelopathy with rigidity and myoclonus.
Topics: Adult; Aged; Baclofen; Central Nervous System Diseases; Cohort Studies; Disease Progression; Female; | 1997 |
15 other studies available for baclofen and Disease Exacerbation
| Article | Year |
|---|---|
Does an intrathecal baclofen pump impact scoliosis progression and complicate posterior spine fusion in patients with cerebral palsy?
Topics: Adolescent; Adult; Baclofen; Cerebral Palsy; Child; Disease Progression; Female; Humans; Infusion Pu | 2020 |
Does Intrathecal Baclofen Therapy Increase Prevalence and/or Progression of Neuromuscular Scoliosis?
Topics: Adolescent; Baclofen; Case-Control Studies; Cerebral Palsy; Chi-Square Distribution; Child; Disease | 2017 |
Botulism: a case of severe intoxication.
Topics: Baclofen; Botulism; Disease Progression; Humans; Male; Muscle Relaxants, Central; Neurologic Examina | 2014 |
Intrathecal baclofen pumps do not accelerate progression of scoliosis in quadriplegic spastic cerebral palsy.
Topics: Baclofen; Case-Control Studies; Cerebral Palsy; Child; Cohort Studies; Disease Progression; Female; | 2017 |
Status dystonicus in children: Early recognition and treatment prevent serious complications.
Topics: Adolescent; Anti-Dyskinesia Agents; Athetosis; Baclofen; Cerebral Palsy; Child; Disease Progression; | 2016 |
[A Pediatric Case of Intractable Cerebrospinal Fluid Leakage after Implantation of an Intrathecal Baclofen Pump].
Topics: Abdomen; Baclofen; Cerebral Palsy; Cerebrospinal Fluid Leak; Child; Disease Progression; Female; Hum | 2017 |
Satisfaction with intrathecal baclofen treatment in paediatric patients with progressive neurological disease.
Topics: Baclofen; Child; Disease Progression; Humans; Injections, Spinal; Muscle Relaxants, Central; Nervous | 2008 |
Do baclofen pumps influence the development of scoliosis in children?
Topics: Adolescent; Aging; Baclofen; Cerebral Palsy; Child; Child, Preschool; Disease Progression; Dystonia; | 2010 |
Spondyloepiphyseal dysplasia tarda with progressive arthropathy complicated with paraplegia.
Topics: Analgesics; Arthralgia; Baclofen; Disease Progression; Follow-Up Studies; Humans; Low Back Pain; Mal | 2011 |
A comparison of hip dislocation rates and hip containment procedures after selective dorsal rhizotomy versus intrathecal baclofen pump insertion in nonambulatory cerebral palsy patients.
Topics: Adolescent; Baclofen; Cerebral Palsy; Child; Child, Preschool; Disease Progression; Female; Follow-U | 2012 |
'Rapid progression of scoliosis complicating intrathecal baclofen pump insertion'.
Topics: Adolescent; Baclofen; Child; Disease Progression; Female; Humans; Infusion Pumps, Implantable; Injec | 2007 |
The risk of progression of scoliosis in cerebral palsy patients after intrathecal baclofen therapy.
Topics: Adolescent; Baclofen; Cerebral Palsy; Child; Child, Preschool; Disease Progression; Female; Humans; | 2007 |
Progression of scoliosis in patients with spastic quadriplegia after the insertion of an intrathecal baclofen pump.
Topics: Adolescent; Adult; Baclofen; Cerebral Palsy; Child; Child, Preschool; Disease Progression; Female; H | 2007 |
Progressive dystonia in a child with chromosome 18p deletion, treated with intrathecal baclofen.
Topics: Adolescent; Baclofen; Chromosome Aberrations; Chromosome Deletion; Chromosome Disorders; Chromosomes | 1999 |
Intrathecal baclofen for intractable spasticity in amyotrophic lateral sclerosis.
Topics: Adult; Amyotrophic Lateral Sclerosis; Baclofen; Catheters, Indwelling; Disease Progression; Dose-Res | 1999 |